Illumina defends Grail acquisition before FTC amid potential divestiture order in Europe

Acquiring Grail would let Illumina help bring cancer tests to market sooner, saving thousands of lives, the company argues. 

By Elise Reuter • Dec. 15, 2022

Apple locked in court battles with small medtech firms over allegations of stolen technology

AliveCor and Masimo are looking to bar Apple from selling watches that use technology the firms claim they invented.

By Elise Reuter , Nick Paul Taylor • Updated Dec. 13, 2022

Apple prevails in AliveCor patent dispute ahead of potential Watch import ban

Patent board ruled that all 30 claims are unpatentable because they are obvious in view of other patents.

By Nick Paul Taylor • Dec. 8, 2022

The 10 biggest medtech stories of 2022

MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

By MedTech Dive staff • Dec. 3, 2022